GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Luoxin Pharmaceutical Group Stock Co Ltd (OTCPK:SLUXY) » Definitions » E10

Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) E10 : $1.21 (As of Mar. 2017)


View and export this data going back to 2009. Start your Free Trial

What is Shandong Luoxin Pharmaceutical Group Stock Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shandong Luoxin Pharmaceutical Group Stock Co's adjusted earnings per share data for the three months ended in Mar. 2017 was $0.198. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $1.21 for the trailing ten years ended in Mar. 2017.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-05), Shandong Luoxin Pharmaceutical Group Stock Co's current stock price is $11.00. Shandong Luoxin Pharmaceutical Group Stock Co's E10 for the quarter that ended in Mar. 2017 was $1.21. Shandong Luoxin Pharmaceutical Group Stock Co's Shiller PE Ratio of today is 9.09.


Shandong Luoxin Pharmaceutical Group Stock Co E10 Historical Data

The historical data trend for Shandong Luoxin Pharmaceutical Group Stock Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Luoxin Pharmaceutical Group Stock Co E10 Chart

Shandong Luoxin Pharmaceutical Group Stock Co Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Shandong Luoxin Pharmaceutical Group Stock Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 1.21

Competitive Comparison of Shandong Luoxin Pharmaceutical Group Stock Co's E10

For the Drug Manufacturers - General subindustry, Shandong Luoxin Pharmaceutical Group Stock Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Luoxin Pharmaceutical Group Stock Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Luoxin Pharmaceutical Group Stock Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shandong Luoxin Pharmaceutical Group Stock Co's Shiller PE Ratio falls into.



Shandong Luoxin Pharmaceutical Group Stock Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shandong Luoxin Pharmaceutical Group Stock Co's adjusted earnings per share data for the three months ended in Mar. 2017 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2017 (Change)*Current CPI (Mar. 2017)
=0.198/103.2000*103.2000
=0.198

Current CPI (Mar. 2017) = 103.2000.

Shandong Luoxin Pharmaceutical Group Stock Co Quarterly Data

per share eps CPI Adj_EPS
200512 0.098 75.666 0.134
200612 0.127 77.793 0.168
200712 0.271 82.911 0.337
200803 0.093 85.485 0.112
200806 0.108 85.058 0.131
200809 0.126 85.057 0.153
200812 0.107 83.956 0.132
200903 0.127 84.457 0.155
200906 0.149 83.615 0.184
200909 0.152 84.369 0.186
200912 0.218 85.386 0.263
201003 0.257 86.316 0.307
201006 0.204 85.886 0.245
201009 0.208 87.267 0.246
201012 0.261 89.289 0.302
201103 0.318 91.154 0.360
201106 0.107 91.612 0.121
201109 0.248 92.711 0.276
201112 0.257 92.885 0.286
201203 0.036 94.367 0.039
201206 0.292 93.495 0.322
201209 0.310 94.482 0.339
201212 0.204 95.237 0.221
201303 0.344 96.372 0.368
201306 0.290 95.984 0.312
201309 0.261 97.332 0.277
201312 0.249 97.624 0.263
201403 0.324 98.600 0.339
201406 0.263 98.200 0.276
201409 0.236 98.900 0.246
201412 0.355 99.000 0.370
201503 0.285 99.900 0.294
201506 0.306 99.500 0.317
201509 0.300 100.500 0.308
201512 0.388 100.600 0.398
201603 0.297 102.200 0.300
201606 0.203 101.400 0.207
201609 9.153 102.400 9.225
201612 0.274 102.600 0.276
201703 0.198 103.200 0.198

Add all the adjusted EPS together and divide 10 will get our e10.


Shandong Luoxin Pharmaceutical Group Stock Co  (OTCPK:SLUXY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shandong Luoxin Pharmaceutical Group Stock Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=11.00/1.21
=9.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Shandong Luoxin Pharmaceutical Group Stock Co E10 Related Terms

Thank you for viewing the detailed overview of Shandong Luoxin Pharmaceutical Group Stock Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Business Description

Traded in Other Exchanges
N/A
Address
Shandong Luoxin Pharmaceutical Group Stock Co Ltd along with its subsidiaries is engaged in the manufacturing and selling of pharmaceutical products. It is involved in the research and development of LXI-15028, a potassium-competitive acid blocker, which is in phase III development for the treatment of reflux esophagitis and other acid-related gastrointestinal diseases; and LXI-15029, an ATP mTOR kinase inhibitor that acts as potent and selective dual inhibitors of mTORC1 and mTORC2 that controls the process of tumor formation and growth. The company mainly operates in the People's Republic of China.

Shandong Luoxin Pharmaceutical Group Stock Co (Shandong Luoxin Pharmaceutical Group Stock Co) Headlines

No Headlines